Clinical Trial Update: Study of gp75 Vaccine in Patients With Stage III and IV Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of the gp75 vaccine in stage III/IV melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• gp75 vaccine

Snippet

Sponsor: Eli Lilly and Company | Conditions: Malignant Melanoma | Phase 1 | Status: COMPLETED